# US 2022/0031735 A1 · Intradialytic use of sodium thiosulfate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031735 A1
- Document ID: US20220031735A1
- Status: Published application
- Kind: A1
- Application number: 17/397,353
- Filed: 2021-08-09
- Published: 2022-02-03
- Earliest claimed: 2017-03-08
- Assignees: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
- Applicants: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
- Inventors: Craig Sherman
- Web page: https://patentgrep.com/patent/US20220031735A1

## CPC

- A61K 33/04: Sulfur, selenium or tellurium; Compounds thereof
- A61M 1/1654: {Dialysates therefor}
- A61M 1/1656: {Apparatus for preparing dialysates}
- A61P 7/08: Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock (artificial tears A61P27/04)
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 9/12: Antihypertensives
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.

## Claims

### Claim at position 1

1-19. (canceled)

### Claim 20

A method for preventing angina, cerebral vasospasm, claudication, critical limb ischemia, peripheral vascular disease, or sickle cell crisis in a subject undergoing dialysis, comprising intradialytically contacting said subject's blood with a dialyzer membrane that is also in contact with a thiosulfate-spiked dialysate, wherein an aqueous solution comprising sodium thiosulfate is added to an unspiked dialysate as the unspiked dialysate flows from a dialysis machine to a dialyzer membrane, wherein said unspiked dialysate comprises a mixture of water, an acid concentrate solution, and a bicarbonate concentrate solution, and wherein said thiosulfate-spiked dialysate has a pH greater than about 7.0, wherein the concentration of thiosulfate in said thiosulfate-spiked dialysate is no more than about 10 micromolar.

### Claim 21 (depends on 20)

The method of claim 20, wherein the physiological level of thiosulfate in said subject is no more than about 10 micromolar.

### Claim 22 (depends on 20)

The method of claim 20, wherein the physiological level of thiosulfate in said subject is between about 500 nanomolar and about 5 micromolar.

### Claim 23 (depends on 20)

The method of claim 20, wherein the physiological level of thiosulfate in said subject is about 3 micromolar.

### Claim 24 (depends on 20)

The method of claim 20, wherein the concentration of thiosulfate in said thiosulfate-spiked dialysate is between about 500 nanomolar and about 5 micromolar.

### Claim 25 (depends on 20)

The method of claim 20, wherein the concentration of thiosulfate in said thiosulfate-spiked dialysate is about 3 micromolar.

### Claim 26 (depends on 20)

The method of claim 20, wherein said aqueous solution comprising sodium thiosulfate comprises no more than about 300 mg/L of sodium thiosulfate.

### Claim 27 (depends on 20)

The method of claim 20, wherein said water comprises no more than about 200 mg/L of thiosulfate.

### Claim 28 (depends on 20)

The method of claim 20, wherein said aqueous solution comprising sodium thiosulfate is added to said unspiked dialysate through a valve that is attached to dialysate tubing at a location before said tubing connects to the dialyzer.

### Claim 29 (depends on 28)

The method of claim 28, wherein said unspiked dialysate flows through said dialysis tubing at a rate between about 500 mL/min and about 700 mL/min.

### Claim 30 (depends on 28)

The method of claim 28, wherein said unspiked dialysate flows through said dialysis tubing at a rate of about 600 mL/min.

### Claim 31 (depends on 28)

The method of claim 28, wherein said aqueous solution comprising sodium thiosulfate is added through said valve to said unspiked dialysate at a rate between about 100 mL/hr and about 550 mL/hr.

### Claim 32 (depends on 28)

The method of claim 28, wherein said aqueous solution comprising sodium thiosulfate is added through said valve to said unspiked dialysate at a rate of about 250 mL per hour.

### Claim 33 (depends on 20)

The method of claim 20, wherein the pH of said thiosulfate-spiked dialysate is between about 7.3 and about 7.5.

### Claim 34 (depends on 20)

The method of claim 20, wherein the pH of said thiosulfate-spiked dialysate is about 7.4.

### Claim 35 (depends on 20)

The method of claim 20, wherein said subject is a human with chronic renal failure.

### Claim 36 (depends on 20)

The method of claim 20, wherein said subject is a human with acute renal failure.

### Claim 37 (depends on 20)

The method of claim 20, wherein said subject undergoes dialysis from three to seven times per week.
